Kalid Alejandra Romero Vega

Dr. Kalid Alejandra Romero Vega

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JCJordana Mariane Neyra Chauca
Jordana Mariane Neyra Chauca
MVMaclovia Vázquez VanDyck
Maclovia Vázquez VanDyck
ASArmando Espinoza Santana
Armando Espinoza Santana
GMGraciela Robles Martinez
Graciela Robles Martinez
KVKalid Alejandra Romero Vega
Kalid Alejandra Romero Vega
VFVANESSA FAVILA
VANESSA FAVILA
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis share common molecular mechanisms involving oxidative stress, neuroinflammation, and microvascular dysfunction. These interrelated processes form a self-perpetuating cycle that accelerates neuronal loss and cognitive decline. Oxidative stress triggers mitochondrial impairment and lipid peroxidation, while chronic glial activation amplifies the inflammatory milieu through cytokine release and reactive oxygen species generation. Concurrently, endothelial and pericytic injury disrupts the blood–brain barrier (BBB), compromising neurovascular coupling and metabolic homeostasis. This review summarizes the mechanistic crosstalk between oxidative, inflammatory, and vascular pathways in neurodegeneration, highlighting recent advances in antioxidant, anti-inflammatory, and vasoprotective strategies. We further discuss emerging therapeutic approaches such as nanocarrier-based delivery systems, multitarget drugs, and genetic modulation aimed at restoring redox balance and microvascular integrity. Understanding the molecular intersections of these mechanisms may provide new insights into disease-modifying interventions for neurodegenerative disorders.